Zai Lab Announces Financial Results for Full Year Ended December 31, 2019 and Corporate Updates

NEXT STORY
Todos Medical Signs Novel Coronavirus (COVID-19) Point-of-Care Rapid Antibody Testing Kit Exclusive Distribution Agreement for the United States and Israel with Shanghai Liangrun Subsidiary Gibraltar
PREV STORY
BioXcel Therapeutics Provides an Update on its Ongoing Phase 3 SERENITY Trials
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BeiGene Presents Updated Head to Head Results from Phase 3 Trial of Zanubrutinib vs. Ibrutinib in Patients with Waldenström’s Macroglobulinemia at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program

author_avatar
NASDAQ Market News

Dry Powder Inhalers Market is slated to Exhibit a CAGR of Nearly 4% during the Forecast Period (2017-2026)

VALLEY COTTAGE, NY , Feb. 08, 2018 (GLOBE NEWSWIRE) -- According to Future Market ...

author_avatar
NASDAQ Market News

NCLA Brief to Mass. Supreme Judicial Court Rebuts Governor Baker’s Defenses

author_avatar
NASDAQ Market News